Have a personal or library account? Click to login
Treatment with lacosamide or levetiracetam in patients with renal replacement therapy. What is really known? Cover

Treatment with lacosamide or levetiracetam in patients with renal replacement therapy. What is really known?

Journal of Epileptology
Volume 28 (2020): Issue 1 (December 2020)
By: Maya Cuhls,  Julian Bösel and  Johannes Rösche  
Open Access
|Apr 2020

Authors

Maya Cuhls

Klinik für Neurologie, Kassel, Germany

Julian Bösel

Klinik für Neurologie, Kassel, Germany

Johannes Rösche

johannes.roesche@med.uni-rostock.de.de

Klinik für Neurologie, Kassel, Germany
Klinik und Poliklinik für Neurologie, Universitätsmedizin Rostock, Rostock, Germany
DOI: https://doi.org/10.21307/joepi-2020-004 | Journal eISSN: 2299-9728 | Journal ISSN: 2300-0147
Journal RSS Feed
Language: English
Page range: 55 - 58
Submitted on: Jan 13, 2020
Accepted on: Mar 26, 2020
Published on: Apr 4, 2020
Published by: The Foundation of Epileptology
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
peritoneal dialysis,
intermittent haemodialysis,
continuous venovenous haemofiltration
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Neurology,
Pharmacology, toxicology,
Pharmacy,
Clinical pharmacy

© 2020 Maya Cuhls, Julian Bösel, Johannes Rösche, published by The Foundation of Epileptology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 28 (2020): Issue 1 (December 2020)Next article